Analyst Ratings for Monsanto: A February Update

Monsanto (MON), which reported its earnings on January 4, 2018, has risen 2.1%. It’s awaiting a merger with Bayer, which continues to be delayed due to anti-trust concerns from regulators in the European Union and other regions. On February 7, 2018, the merger received approval from Brazilian antitrust regulators. As of February 22, 2018, the consensus mean rating for Monsanto from 18 analysts surveyed by Reuters was 2.6 with an overall “hold” recommendation for the next 12-month period.